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Sir Editor,
Situation-related generalised non-convulsive status epilepticus
(NCSE) is a condition which generally occurs in non-epileptic
adults or elderly subjects precipitated by drugs, toxics, metabolic
disturbances or electroconvulsive therapy. Diverse pharmacologi-
cal agents such as psychotropics, cephalosporins and antineoplas-
tic drugs have been mentioned in the past as frequent cause of
drug-induced generalised NCSE.1 We report herein to the best of
our knowledge, the ﬁrst case of generalised NCSE precipitated by
the use of piperacillin–tazobactam.
A 63-year-old woman without previous history of epilepsy was
transferred to our hospital because of the occurrence of two
generalised tonic–clonic seizures in the context of urinary sepsis.
She had antecedents of Parkinson disease and personality disorder.
During the last 10 days she had been diagnosed with urinary tract
infection and had been taking fosfomycin without clinical
improvement. Physical exanimation revealed a temperature of
38.2 8C. On neurologic examination she was alert and able to
respond simple commands. No focalmotor or sensory deﬁcitswere
seen. Routine laboratory tests showed an increased peripheral
white blood cell count (19 400 cells/mm3) and pyuria but
otherwise were unremarkable. A computed tomography (CT) scan
of the brain was considered normal. Cerebrospinal ﬂuid revealed
also normal values. Treatment with intravenous piperacillin/
tazobactam (1500 mg/24 h) and phenytoin (300 mg/24 h) was
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slowing of background activity suggestive of a mild diffuse
encephalopathy. During the following 4 days, fever and urinary
symptoms slightly improved; however, she developed a progres-
sive worsening of her level of consciousness and mental state. On
neurologic examination she was stuporous with poor spontaneous
speech. At that moment, a second brain CT did not reveal
signiﬁcant changes. However, an urgent EEG showed intermittent
generalised burst of polyspike-wave and spike-wave complexes at
1–2 Hz with frontal maximum in keeping with the diagnosis of
generalised NCSE (Fig. 1). Piperacillin/tazobactam and phenytoin
were discontinued, and intravenous treatment with ciproﬂoxacin,
phenobarbital and clonazepam was initiated. Three days later, the
patient had a slight recovery of her level of consciousness and a
third EEG showed an excess of thetawaves and frontal intermittent
rhythmic delta activity without epileptiform discharges. During
the next 15 days she experienced a gradual clinical improvement
with some ﬂuctuations on hermental status. Several EEGs revealed
ﬁndings compatible with a diffuse encephalopathy but epilepti-
form activity never recurred. Finally, the patient was discharged
with a normal baseline mental status.
Piperacillin/tazobactamisabeta-lactam/beta-lactamase inhibitor
combination with a broad spectrum of antibacterial activity against
most Gram-positive and Gram-negative aerobic and anaerobic
bacteria. Piperacillin/tazobactam has been associatedwith relatively
low incidence of epileptic seizures.2 Others b-lactam antibiotics
such as imipenem have been also related to diverse neurologic
complications including encephalopathy, seizures and myoclonus.3
Psychotropics, cephalosporins, antineoplastic agents, baclofen,
cyclosporin, chloroquine and morphine have been occasionallyike-wave discharges compatible with the diagnosis of generalised NCSE. Low ﬁlter:
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This epileptic condition affects often inpatients, generally adults or
elderly people with moderate or severe subjacent pathology such
as sepsis, infectious processes, renal failure, cancer or other
metabolic derangements. It seems thatmany of these drugs share a
similar pathophysiological mechanism since they can modify the
intrinsic activity of diffuse inhibitory brain circuits mediated by
gamma-aminobutyric acid, reducing the critical seizure threshold
and precipitating the occurrence of generalised epileptiform
discharges. As in our case both encephalopathy and NCSE may
coexist above all in elderly patients with pluripathology.6 Under
these circumstances, it is difﬁcult to determine exactly the
contribution that seizure activity had in the development of the
confusional picture. However, the clinical changes following the
modiﬁcation of the treatment support its role in patient’s stupor.
In summary, the diagnosis of generalised NCSE should be
considered in all patients with unexpected changes inmental state
on treatment with intravenous piperacillin/tazobactam. A high
level of clinical suspicion, broad metabolic screening and, an
emergent EEG are essential to obtain a prompt and accurate
diagnosis.
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